GoodRx Holdings, Inc.GDRXNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.99% | +2.57% | +1.23% | +0.40% | -1.91% |
| Gross Profit Growth | +2.71% | +2.26% | -9.93% | -0.52% | -39.95% |
| EBITDA Growth | +23.88% | +56.18% | +15.88% | -5.13% | +19.56% |
| Operating Income Growth | +0.00% | +216.76% | +39.40% | -28.36% | +126.96% |
| Net Income Growth | +0.00% | +0.00% | +91.86% | -90.87% | -19.51% |
| EPS Growth | +0.00% | +0.00% | +80.00% | -90.09% | -20.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +80.00% | -89.87% | -20.50% |
| Weighted Average Shares Growth | -4.64% | -2.78% | -5.22% | -8.38% | -10.85% |
| Weighted Average Shares Diluted Growth | -4.15% | -2.66% | -7.17% | -10.47% | -11.16% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +181.97% | -77.90% | +411.08% | -12.48% | -26.50% |
| Free Cash Flow Growth | +837.88% | -156.72% | +0.00% | -32.89% | +12.63% |
| Receivables Growth | +0.49% | +6.22% | +6.71% | +35.90% | +46.58% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -12.63% | -10.91% | -10.62% | -2.17% | +1.15% |
| Book Value per Share Growth | -0.27% | +6.66% | +1.35% | -5.85% | -4.61% |
| Debt Growth | -23.58% | -23.80% | -22.60% | +0.10% | -89.04% |
| R&D Expense Growth | -0.91% | +0.40% | -2.99% | +2.90% | -8.82% |
| SG&A Expenses Growth | -5.44% | -12.89% | -6.44% | +0.05% | -12.63% |